|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| C07H 21/04 | |||
| A61K 31/7088 |
| (11) | Number of the document | 1954836 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06844293.8 |
| Date of filing the European patent application | 2006-11-08 | |
| (97) | Date of publication of the European application | 2008-08-13 |
| (45) | Date of publication and mention of the grant of the patent | 2014-01-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/043507 |
| Date | 2006-11-08 |
| (87) | Number | WO 2007/056466 |
| Date | 2007-05-18 |
| (30) | Number | Date | Country code |
| 735000 P | 2005-11-08 | US | |
| 799976 P | 2006-05-11 | US |
| (72) |
MOURICH, Dan, V., US
IVERSEN, Patrick, L., US
WELLER, Dwight, D., US
|
| (73) |
Sarepta Therapeutics, Inc.,
3450 Monte Villa Parkway, Suite 101, Bothell, Washington 98021,
US
|
| (54) | Immunosuppression compound and treatment method |
| Immunosuppression compound and treatment method |